Rafael Holdings Class B (RFL) closed at $1.04 on November 6, 2026, down 1.9% from the previous close, on volume of 43,184 shares (30-day average 161,335).
Data as of November 6, 2026.
6-Nov-2026
| # | Date | Strategy | Legs | Contracts |
|---|
Ranked by contracts: multi-leg trades of 200 or more contracts on one day, through Nov 6, 2026. See the 10 largest for 30, 60 and 90 days
No headlines found.
Globe Newswire (Tue, 3-Nov 5:20 PM ET)
Rafael Holdings to Participate in the Guggenheim 3rd Annual Healthcare Innovation Conference
Globe Newswire (Tue, 3-Nov 11:14 AM ET)
Globe Newswire (Thu, 29-Oct 8:00 AM ET)
Globe Newswire (Thu, 29-Oct 7:00 AM ET)
Globe Newswire (Tue, 27-Oct 6:42 PM ET)
Globe Newswire (Wed, 30-Sep 7:00 AM ET)
Globe Newswire (Mon, 10-Aug 9:01 AM ET)
Rafael Holdings Inc is a biotechnology firm that develops pharmaceuticals and invests in clinical and early-stage companies in pharmaceuticals and medical devices. Trappsol Cyclo is in Phase 3 trials for Niemann-Pick Disease Type C1. The company focuses on completing these trials, seeking regulatory approval, and commercializing the product. It also invests in portfolio companies including Cyclo, LipoMedix, Barer, Rafael Medical Devices, Cornerstone, and Day Three, targeting therapeutics for unmet medical needs. The business operates through three segments: Healthcare, Infusion Technology, and Real Estate. Operations are based in the United States and Israel.
Rafael Holdings Class B trades on the NYSE stock market under the symbol RFL.
As of November 6, 2026, RFL stock price declined to $1.04 with 43,184 million shares trading.
RFL has a beta of 0.31, meaning it tends to be less sensitive to market movements. RFL has a correlation of 0.00 to the broad based SPY ETF.
RFL has a market cap of $54.27 million. This is considered a Micro Cap stock.
In the last 3 years, RFL traded as high as $3.96 and as low as $.99.
The top ETF exchange traded funds that RFL belongs to (by Net Assets): VTI, VXF, IWC, DFMC, DFAS.
RFL has underperformed the market in the last year with a price return of -19.9% while the SPY ETF gained +10.8%. RFL has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -48.5% and -20.6%, respectively, while the SPY returned -4.1% and -3.2%, respectively.
RFL support price is $.98 and resistance is $1.14 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that RFL shares will trade within this expected range on the day.
